TH3RESA_4 | R Documentation |
Kaplan-Meier digitized data from TH3RESA, figure 4 (PMID 24793816). A reported sample size of 602 for a primary endpoint of PFS/OS in breast cancer.
TH3RESA_4
A data frame of 602 observations and 3 variables:
time | event time (in months) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (physicians_choice, trastuzumab_emtansine) | |
Krop IE, Kim S-B, González-Martín A, et al. Trastuzumab emtansine versus treatment of physician’s choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial. Lancet Oncol 2014; 15: 689–99.
summary(TH3RESA_4)
kmplot(TH3RESA_4)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.